HarmonyCA – Allergan | Hyaluronic Filler Market

HarmonyCA – Allergan

Description HARmonyCA

Allergan, the French leader in injectables and pioneer in anti-hair removal products, has launched HARmonyCA, a combined injectable of hyaluronic acid and collagen

A revolution in injectable products for aesthetic medicine

features

Global pharmaceutical company Allergan Aesthetics has launched HARmonyCa, an injectable hybrid treatment that combines hyaluronic acid (HA) and calcium hydroxyapatite (CaHA).

HARmonyCa has a double effect, Ha offers a instant lift and CaHA causes a new collagen production

HarmonyCa is intended for the augmentation of sagging facial tissue by injection into the deep dermal and subdermal layers.

Results

The cross-linked AH gel provides an immediate lifting effect and is sculptable, allowing a qualified cosmetic surgeon to adjust the implant’s shape after delivery

Hyaluronic acid microbeads that promote the body’s own collagen production by inducing the formation of collagen fibers

The hyaluronic acid particles work deep in the skin, where they help to plump up the skin for an instant lifting effect, while the CaHA microspheres support the body’s own collagen production so that new collagen fibers begin to grow. The newly formed collagen fibers can already be present a week after the treatment.

Over 90% of patients reported an improvement in the overall appearance of facial features after treatment with HARmonyCa.

It is the first hybrid injectable on the market. Its potential to provide immediate hyaluronic acid lifting and lasting collagen stimulation coupled with calcium hydroxyapatite meets some of the multidimensional needs of aging skin.